Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 12/2007

01-12-2007 | Original Article

Oxidative stress in lymphocytes, neutrophils, and serum of oral cavity cancer patients: modulatory array of l-glutamine

Authors: Subhasis Das, Santanu Kar Mahapatra, N. Gautam, Amrita Das, Somenath Roy

Published in: Supportive Care in Cancer | Issue 12/2007

Login to get access

Abstract

Objectives

Our aim was to assess the oxidative stress and ameliorative effect of l-glutamine in serum, neutrophils, and lymphocytes of oral cancer patients by measuring the levels of malondialdehyde (MDA) and antioxidants.

Materials and methods

This study has been conducted on serum and specific blood cells in adult, male oral cancer patients (stage III-6, stage IV-42) and normal subjects of an equal number of age and sex-matched disease-free healthy subjects. The levels of lipid peroxidation and antioxidant enzymes were assayed using spectrophotometric methods.

Results

MDA levels were elevated, and antioxidant enzyme status was decreased significantly in all groups of cancer patients simultaneously, but after supplementation of “glutammune” (66.66% l-glutamine), oxidative stress has been alleviated to some extent; especially, it has repaired the glutathione cascade system.

Conclusion

We conclude that oxidative stress is due to the enhanced lipid peroxidation and decrease in antioxidant enzymes, and it can be restored with dietary supplementation of l-glutamine related drug.
Literature
1.
Akobeng AK, Miller V, Stanton J et al (2000) Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn’s disease. J Pediatr Gastroenterol Nutr 30:78–84PubMedCrossRef
2.
Akobeng AK, Miller V, Thomas AG, Richmond K (2000) Glutamine supplementation and intestinal permeability in Crohn’s disease. J Parenter Enteral Nutr 24:196
3.
Ames BN, Shigenega MK, Hagen TM (1993) Oxidant, antioxidant and degenerative diseases of ageing. Proc Natl Acad Sci USA 90:7915–7922PubMedCrossRef
4.
Beers RF, Sizer IW (1952) A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem 195:133–140PubMed
5.
Bingisser RM, Tilbrook PA, Holt PG, Kees UR (1998) Macrophage-derived nitric oxide regulates T-cell activation via reversible disruption of the Jak3/STAT5 signaling pathway. J Immunol 160:5729–5734PubMed
6.
Burdon RH (1995) Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med 18:775–794PubMedCrossRef
7.
8.
9.
Darmaun D (2000) Role of glutamine depletion in severe illness. Diabetes Nutr Metab 13:25–30PubMed
10.
Den Hond E, Hiele M, Peeters M, Ghoos Y, Rutgeerts P (1999) Effect of long-term oral glutamine supplements on small intestinal permeability in patients with Crohn’s disease. J Parenter Enteral Nutr 23:7–11CrossRef
11.
12.
Enwonwu CO, Meeks VI (1995) Bionutrition and oral cancer in humans. Crit Rev Oral Biol Med 6(1):5–17PubMedCrossRef
13.
Garewal H (1995) Antioxidants in oral cancer. Am J Clin Nutr 62(Suppl):1410S–1416S
14.
Gayle K, Savy RD (1997) Enteral glutamine supplementation: clinical review and practical guidelines. Nutr Clin Prac 12(6):259–262CrossRef
15.
Grifith OW (1980) Determination of glutathione and glutathione sulfide using glutathione reductase and 2-vinyl pyridine. Anal Biochem 106:207CrossRef
16.
Gupta A, Batts B, Kwei KA, Dvorakova K, Stratton SP, Briehl MM et al (2001) Attenuation of catalase activity in the malignant phenotype plays a functional role in an in vitro model for tumor progression. Cancer Lett 73:115–125CrossRef
17.
Habig WH, Pabst MJ, Jakoby WB (1974) Glutathione S-transferases: the first enzymatic step in mercapyuric acid formation. J Biol Chem 249:7130–7139PubMed
18.
Hasnis E, Reznick AZ, Pollack S, Klein Y, Nagler RM (2004) Synergistic effect of cigarette smoke and saliva on lymphocytes—the mediatory role of volatile aldehydes and redox active iron and the possible implications for oral cancer. Int J Biochem Cell Biol 36(5):826–839PubMedCrossRef
19.
Hassan HM, Fridovich I (1978) Superoxide radical and the oxygen enhancement of the toxicity of paraquat in E. coli. J Biol Chem 253:8143–8148PubMed
20.
Hristozov D, Gadjeva V, Vlaykova T, Dimitrov G (2001) Evaluation of oxidative stress in patients with cancer. Arch Physiol Biochem 109:331–336PubMed
21.
Hudson L, Hay FC (1991) Practical immunology. Blackwell Scientific Publications, Oxford University Press, pp 21–22
22.
23.
Kumaraguruparan R, Subapriya R, Kabalimoorthy J, Nagini S (2002) Antioxidant profile in the circulation of patients with fibroadenoma and adenocarcinoma of the breast. Clin Biochem 35:275–279PubMedCrossRef
24.
Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:255–275
25.
Malmberg KJ, Lenkei R, Petersson M et al (2002) A short-term dietary supplementation of high doses of vitamin E increases T helper 1 cytokine production in patients with advanced colorectal cancer. Clin Cancer Res 8:772–778
26.
Manju V, Sailaja JK, Nalini N (2002) Circulating lipid peroxidation and antioxidant status in cervical cancer patients: a case-control study. Clin Biochem 35:621–625PubMedCrossRef
27.
Mantovani G, Maccio A, Madeddu C, Mura L, Gramignano G, Lusso MR, Mulas C, Mudu MC, Murgia V, Camboni P, Massa E, Ferreli L, Contu P, Rinaldi A, Sanjust E, Atzei D, Elsener B (2002) Quantitative evaluation of oxidative stress, chronic inflammatory indexes and leptin in cancer patients: correlation with stage and performance status. Int J Cancer 98:84–91PubMedCrossRef
28.
Mantovani G, Maccio A, Madeddu C, Mura L, Massa E, Gramignano G, Lusso MR, Murgia V, Camboni P, Ferreli L (2002) Reactive oxygen species, antioxidant mechanisms and serum cytokine levels in cancer patients: impact of an antioxidant treatment. J Cell Mol Med 6(4):570–582PubMedCrossRef
29.
Marklund S, Marklund G (1974) Involvement of superoxide anion radical in autoxidation of pyrogallol and a convenient assay of superoxide dismutase. Eur J Biochem 47:469–474PubMedCrossRef
30.
Mates JM, Perez-Gomez C, Nunez de Castro I (1999) Antioxidant enzymes and human disease. Clin Biochem 32:595–603PubMedCrossRef
31.
Meister A (1988) Glutathione metabolism and its selective modification. J Biochem 263:17205–17208
32.
Melis GC, Wengel N, Boelens PG, Leeuwen P (2004) Glutamine: recent developments in research on the clinical significance of glutamine. Curr Opin Clin Nutr Metab Care 7(1):59–70PubMedCrossRef
33.
Muir CS, Kirk R (1990) Betel, tobacco and cancer of the mouth. Br J Cancer 14:597–608
34.
Oberley LW, Oberley TD (1988) Role of antioxidant enzymes in cell immortalization and transformation. Mol Cell Biochem 84:147–153PubMedCrossRef
35.
Oda D, Nguyen MP, Royack GA, Tong DC (2001) H2O2 oxidative damage in cultured oral epithelial cells: the effect of short-term vitamin C exposure. Anticancer Res 21(4A):2719–2724PubMed
36.
Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358PubMedCrossRef
37.
Parkin SM, Laara E, Muir CS (1988) Estimates of the worldwide frequency of sixteen major cancers. Int J Cancer 41:184–197PubMedCrossRef
38.
Ray G, Batra S, Shukla NK, Deo S, Raina V, Ashok S, Husain SKI (2000) Lipid peroxidation, free radical production and antioxidant status in breast cancer. Breast Cancer Res Treat 59:163–170PubMedCrossRef
39.
Reznick AZ, Klein I, Eiserich JP, Cross CE, Nagler RM (2003) Inhibition of oral peroxidase activity by cigarette smoke: in vivo and in vitro studies. Free Radic Biol Med 34(3):377–384PubMedCrossRef
40.
Sandhu SKI, Kaur G (2002) Alterations in oxidative stress scavenger system in aging rat brain and lymphocytes. Biogerontology 3:161–173PubMedCrossRef
41.
Sankaranarayana R (1990) Oral cancer in India: an epidemiologic and clinical review. Oral Surg Oral Med Oral Pathol 69:325–330CrossRef
42.
Sieja K (1998) Selenium (Se) deficiency in women with ovarian cancer undergoing chemotherapy and the influence of supplementation with this micro-element on biochemical parameters. Pharmazie 53(7):473–476PubMed
43.
Singh A, Singh SP (1997) Modulatory potential of smokeless tobacco on the garlic, mace or black mustard-altered hepatic detoxication system enzymes sulphydryl contents and lipid peroxidation in murine system. Cancer Lett 118:109–114PubMedCrossRef
44.
Souba WW (1993) Intestinal glutamine metabolism and nutrition. J Nutr Biochem 4:2–9CrossRef
45.
Stitch HF, Anders F (1989) The involvement of reactive oxygen species in oral cancer of betel quid-tobacco chewers. Mutat Res 214:47–61
46.
Sun Y (1990) Free radicals, antioxidant enzymes and carcinogenesis. Free Radic Biol Med 8:583–599PubMedCrossRef
47.
Syed Sultan Beevi S, Muzib Hassanal Rasheed A, Geetha A (2004) Evaluation of oxidative stress and nitric oxide levels in patients with oral cavity cancer. Jpn J Clin Oncol 34(7):379–385PubMedCrossRef
48.
US Department of Health and Human Services (1982) The health consequences of smoking and cancer. A report of the Surgeon General. US Government Printing Office, Washington, DC [DDHS publication (P511) no. 5107]
49.
Wu HJ, Chi CW, Liu TY (2005) Effect of nicotine-induced DNA damage and oxidative stress. J Toxicol Environ Health 68(17–18):1511–1523CrossRef
50.
Zhang Y, Chen SY, Hsu T, Santella RM (2002) Immunohistochemical detection of malondialdehyde-DNA adducts in human oral mucosa cells. Carcinogenesis 23:207–211PubMedCrossRef
51.
Ziegler TR, Bazargan, N, Leader LM, Martindale RG (2000) Glutamine and the intestinal tract. Curr Opin Clin Nutr Metab Care 3:355–362PubMedCrossRef
52.
Ziegler TR, Puckett AB, Griffiths DP, Galloway JR (1997) Interactions between nutrients and growth factors in cellular growth and tissue repair. In: Ziegler TR, Pierce GF, Herdon DN (eds) Growth factors and wound healing: basic science and potential clinical applications. Springer, New York, pp 104–150
Metadata
Title
Oxidative stress in lymphocytes, neutrophils, and serum of oral cavity cancer patients: modulatory array of l-glutamine
Authors
Subhasis Das
Santanu Kar Mahapatra
N. Gautam
Amrita Das
Somenath Roy
Publication date
01-12-2007
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 12/2007
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-007-0266-3

Other articles of this Issue 12/2007

Supportive Care in Cancer 12/2007 Go to the issue

Original Article

Dying at home or in an institution: perspectives of Dutch physicians and bereaved relatives

Original Article

Sources of strength perceived by females caring for relatives diagnosed with cancer: an exploratory study from India

Original Article

Patterns of use of vascular access devices in patients undergoing hematopoietic stem cell transplantation: results of an international survey

Original Article

Endocrine symptom assessment in women with breast cancer: what a simple “yes” means

Short Communication

Efficacy of the BioXtra dry mouth care system in the treatment of radiotherapy-induced xerostomia

Review Article

Diagnosis and management of hyponatremia in cancer patients
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits